|
π
|
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.
19 auth.
H. Okada,
M. Weller,
Raymond Y Huang,
G. Finocchiaro,
M. Gilbert,
W. Wick,
B. Ellingson,
N. Hashimoto,
I. Pollack,
A. Brandes,
...
E. Franceschi,
C. HeroldβMende,
L. Nayak,
A. Panigrahy,
W. Pope,
R. Prins,
J. Sampson,
P. Wen,
D. Reardon
|
9 |
2015 |
9
π
|
|
π
|
Fiber-tracking does not accurately estimate size of fiber bundle in pathological condition: initial neurosurgical experience using neuronavigation and subcortical white matter stimulation
9 auth.
M. Kinoshita,
Kei Yamada,
N. Hashimoto,
A. Kato,
S. Izumoto,
Takahito Baba,
...
M. Maruno,
T. Nishimura,
T. Yoshimine
|
8 |
2005 |
8
π
|
|
π
|
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme.
22 auth.
S. Izumoto,
A. Tsuboi,
Y. Oka,
Tsuyoshi Suzuki,
Tetsuo Hashiba,
Naoki Kagawa,
N. Hashimoto,
M. Maruno,
O. Elisseeva,
T. Shirakata,
...
M. Kawakami,
Y. Oji,
S. Nishida,
S. Ohno,
I. Kawase,
J. Hatazawa,
S. Nakatsuka,
K. Aozasa,
S. Morita,
J. Sakamoto,
H. Sugiyama,
T. Yoshimine
|
7 |
2008 |
7
π
|
|
π
|
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
53 auth.
Hideyuki Arita,
K. Yamasaki,
Y. Matsushita,
Taishi Nakamura,
Asanao Shimokawa,
Hirokazu Takami,
Shota Tanaka,
A. Mukasa,
M. Shirahata,
S. Shimizu,
Kaori Suzuki,
Kuniaki Saito,
Keiichi Kobayashi,
Fumi Higuchi,
T. Uzuka,
...
Ryohei Otani,
Kaoru Tamura,
Kazutaka Sumita,
M. Ohno,
Y. Miyakita,
Naoki Kagawa,
N. Hashimoto,
Ryusuke Hatae,
K. Yoshimoto,
N. Shinojima,
Hideo Nakamura,
Y. Kanemura,
Y. Okita,
M. Kinoshita,
Kenichi Ishibashi,
T. Shofuda,
Y. Kodama,
K. Mori,
Y. Tomogane,
J. Fukai,
K. Fujita,
Y. Terakawa,
N. Tsuyuguchi,
S. Moriuchi,
M. Nonaka,
Hiroyoshi Suzuki,
M. Shibuya,
T. Maehara,
N. Saito,
M. Nagane,
N. Kawahara,
K. Ueki,
T. Yoshimine,
Etsuo Miyaoka,
R. Nishikawa,
T. Komori,
Y. Narita,
K. Ichimura
|
7 |
2016 |
7
π
|
|
π
|
Prognostic Value of Medulloblastoma Extent of Resection After Accounting for Molecular Subgroup: An Integrated Clinical and Molecular Analysis
107 auth.
E. Thompson,
T. Hielscher,
E. Bouffet,
M. Remke,
B. Luu,
S. Gururangan,
R. McLendon,
D. Bigner,
E. Lipp,
S. Perreault,
Yoon-Jae Cho,
G. Grant,
Seung-Ki Kim,
Seung-Ki Kim Ji Yeoun Lee,
A. N. Rao,
...
C. Giannini,
K. Li,
H. Ng,
Yu Yao,
T. Kumabe,
T. Tominaga,
W. Grajkowska,
M. Perek-Polnik,
D. C. Low,
W. Seow,
K. Chang,
J. Mora,
I. Pollack,
R. Hamilton,
S. Leary,
A. Moore,
W. J. Ingram,
A. Hallahan,
A. Jouvet,
M. Fèvre-Montange,
A. Vasiljevic,
C. Faure-Conter,
T. Shofuda,
Naoki Kagawa,
N. Hashimoto,
N. Jabado,
A. Weil,
T. Gayden,
T. Wataya,
T. Shalaby,
M. Grotzer,
K. Zitterbart,
J. Ε tΔrba,
L. KΕen,
T. HortobΓ‘gyi,
Γ. Klekner,
B. LΓ‘szlΓ³,
T. PΓ³cza,
P. Hauser,
U. SchΓΌller,
Shin Jung,
W. Jang,
P. French,
J. Kros,
M. van Veelen,
L. Massimi,
J. Leonard,
J. Rubin,
Rajeev Vibhakar,
L. Chambless,
M. K. Cooper,
R. Thompson,
C. Faria,
A. Carvalho,
S. Nunes,
J. Pimentel,
Xing Fan,
K. Muraszko,
E. LΓ³pez-Aguilar,
D. Lyden,
L. Garzia,
D. Shih,
Noriyuki Kijima,
C. Schneider,
J. Adamski,
P. Northcott,
M. Kool,
David T. W. Jones,
J. Chan,
A. NikoliΔ,
M. Garrè,
Erwin G. Van Meir,
S. Osuka,
J. Olson,
Arman Jahangiri,
Brandyn Castro,
N. Gupta,
W. Weiss,
I. Moxon-Emre,
D. Mabbott,
Γ. Lassaletta,
C. Hawkins,
U. Tabori,
J. Drake,
A. Kulkarni,
P. Dirks,
J. Rutka,
A. Korshunov,
S. Pfister,
R. Packer,
V. Ramaswamy,
Michael D. Taylor
|
7 |
2016 |
7
π
|
|
π
|
Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas
23 auth.
Taishi Nakamura,
K. Tateishi,
T. Niwa,
Y. Matsushita,
Kaoru Tamura,
M. Kinoshita,
Kazuhiro Tanaka,
Shintaro Fukushima,
Hirokazu Takami,
Hideyuki Arita,
...
A. Kubo,
T. Shuto,
M. Ohno,
Y. Miyakita,
S. Kocialkowski,
T. Sasayama,
N. Hashimoto,
T. Maehara,
S. Shibui,
T. Ushijima,
N. Kawahara,
Y. Narita,
K. Ichimura
|
7 |
2016 |
7
π
|
|
π
|
Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors
9 auth.
M. Kinoshita,
N. Hashimoto,
T. Goto,
Naoki Kagawa,
H. Kishima,
S. Izumoto,
...
Hisashi Tanaka,
N. Fujita,
T. Yoshimine
|
7 |
2008 |
7
π
|
|
π
|
Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas.
8 auth.
Tetsuo Hashiba,
N. Hashimoto,
S. Izumoto,
Tsuyoshi Suzuki,
Naoki Kagawa,
M. Maruno,
...
A. Kato,
T. Yoshimine
|
7 |
2009 |
7
π
|
|
π
|
Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial.
50 auth.
T. Kayama,
Shinya Sato,
K. Sakurada,
J. Mizusawa,
R. Nishikawa,
Y. Narita,
M. Sumi,
Y. Miyakita,
T. Kumabe,
Y. Sonoda,
Y. Arakawa,
S. Miyamoto,
T. Beppu,
K. Sugiyama,
Hirohiko Nakamura,
...
M. Nagane,
Y. Nakasu,
N. Hashimoto,
Mizuhiko Terasaki,
A. Matsumura,
E. Ishikawa,
T. Wakabayashi,
Y. Iwadate,
S. Ohue,
Hiroyuki Kobayashi,
M. Kinoshita,
Kenichiro Asano,
A. Mukasa,
Katsuyuki Tanaka,
A. Asai,
Hideo Nakamura,
T. Abe,
Y. Muragaki,
K. Iwasaki,
T. Aoki,
Takao Watanabe,
H. Sasaki,
S. Izumoto,
M. Mizoguchi,
T. Matsuo,
H. Takeshima,
M. Hayashi,
H. Jokura,
T. Mizowaki,
E. Shimizu,
H. Shirato,
M. Tago,
H. Katayama,
H. Fukuda,
S. Shibui
|
7 |
2018 |
7
π
|
|
π¦
|
Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies.
11 auth.
N. Hashimoto,
Carter S. Rabo,
Y. Okita,
M. Kinoshita,
Naoki Kagawa,
Y. Fujimoto,
...
E. Morii,
H. Kishima,
M. Maruno,
A. Kato,
T. Yoshimine
|
6 |
2012 |
6
π¦
|
|
π
|
Diffusion tensor fiber tracking in patients with central post-stroke pain; correlation with efficacy of repetitive transcranial magnetic stimulation
10 auth.
T. Goto,
Y. Saitoh,
N. Hashimoto,
M. Hirata,
H. Kishima,
S. Oshino,
...
N. Tani,
K. Hosomi,
R. Kakigi,
T. Yoshimine
|
6 |
2008 |
6
π
|
